Jin Medical International Ltd. has notified the United States Securities and Exchange Commission (SEC) of a delay in filing its Annual Report on Form 20-F for the period ended September 30, 2023. The company cited the delay in finalizing its financial statements and other disclosures as the reason for not meeting the original filing deadline, which has resulted in undue hardship and expense. Jin Medical International has stated that it expects to file the report no later than fifteen calendar days following the prescribed due date. The notification, signed by CEO Erqi Wang on January 31, 2024, also confirms that all other periodic reports required by the SEC have been filed and anticipates significant changes in the results of operations from the last fiscal year to be reflected in the upcoming earnings statements.

Jin Medical International Ltd. has notified the United States Securities and Exchange Commission (SEC) of a delay in filing its Annual Report on Form 20-F for the period ended September 30, 2023. The company cited the delay in finalizing its financial statements and other disclosures as the reason for not meeting the original filing deadline, which has resulted in undue hardship and expense. Jin Medical International has stated that it expects to file the report no later than fifteen calendar days following the prescribed due date. The notification, signed by CEO Erqi Wang on January 31, 2024, also confirms that all other periodic reports required by the SEC have been filed and anticipates significant changes in the results of operations from the last fiscal year to be reflected in the upcoming earnings statements.